Search
Search Results
-
Approaches to prevention of gynecological malignancies
Gynecological malignancies represent one of the prevalent diseases in the female sex and prevention is essential to limit their incidence and...
-
Microvessel Density Assessment in Gynecological Malignancies
IntroductionGynecological malignancies are one of the leading causes of early mortality in women of all ages, whether they originate from any part of...
-
Cancer-associated thrombosis in hematologic malignancies
Patients with hematologic malignancies are often complicated not only by severe bleeding due to thrombocytopenia and disseminated intravascular...
-
Palliative Care Needs of Patients with Musculoskeletal Malignancies
Purpose of ReviewThis review aims to assess the literature regarding current treatment options for the palliative care of patients with advanced...
-
Genomic testing for germline predisposition to hematologic malignancies
Germline predisposition (GPD) to hematological malignancies has gained interest because of the increased use of genetic testing in this field. Recent...
-
Advances in CAR-T-cell therapy in T-cell malignancies
Significant advances have been made in chimeric antigen receptor T (CAR-T)-cell therapy for the treatment of recurrent or refractory B-cell...
-
Malignancies of the Nasal Vestibule A New Perspective on Classification, Staging, and Treatment
This book provides up-to-date information on nasal vestibule malignancies, outlining the specific clinical history and pattern of spread. It also...
-
Epigenetic regulation by ASXL1 in myeloid malignancies
Myeloid malignancies are clonal hematopoietic disorders that are comprised of a spectrum of genetically heterogeneous disorders, including...
-
Revisiting intrathecal thiotepa: Efficacy and safety in secondary CNS malignancies
Treating metastatic malignancies to the central nervous system (CNS) is challenging because many drugs cannot cross the blood-brain-barrier (BBB)....
-
Novel treatment strategies for hematological malignancies in the immunotherapy era
The introduction of immunotherapies has led to remarkable progress in the treatment of hematological malignancies, including B-cell malignancies such...
-
Genomic technologies for detecting structural variations in hematologic malignancies
Genomic structural variations in myeloid, lymphoid, and plasma cell neoplasms can provide key diagnostic, prognostic, and therapeutic information...
-
Incidence of second malignancies in patients with thymic carcinoma and thymic neuroendocrine tumor
ObjectivesThymic carcinoma and thymic neuroendocrine tumor (NET) are rare and are more likely to develop second malignancies. The purpose of this...
-
Chimeric antigen receptor T cells march into T cell malignancies
T cell malignancies represent a diverse collection of leukemia/lymphoma conditions in humans arising from aberrant T cells. Such malignancies are...
-
Spine involvement in hematological malignancies: a review
Hematological malignancies are tumors of the bone marrow and lymphatic system cells. Leukemia, Lymphoma, Multiple Myeloma and Plasmacytoma are the...
-
Immunotherapy in hematologic malignancies: achievements, challenges and future prospects
The immune-cell origin of hematologic malignancies provides a unique avenue for the understanding of both the mechanisms of immune responsiveness and...
-
Chromothripsis in myeloid malignancies
Chromothripsis refers to massive genomic rearrangements developed during a catastrophic event. In total acute myeloid leukemia (AML), the incidence...
-
Human Papillomavirus in Sinonasal Malignancies
Purpose of ReviewThe purpose of this review is to convey to the reader the most recent literature on the association between human papillomavirus...
-
Nephrotic syndrome associated with solid malignancies: a systematic review
BackgroundNephrotic syndrome (NS) can occur as a paraneoplastic disorder in association with various types of carcinoma. However, paraneoplastic...
-
Lymphatic drainage of sinonasal malignancies and the role of sentinel node biopsies
BackgroundLocoregional recurrence is a critical factor in the prognosis of sinonasal malignancies. Due to the rarity of these tumours, as well as the...
-
An “off-the-shelf” CD2 universal CAR-T therapy for T-cell malignancies
T-cell malignancies are associated with frequent relapse and high morbidity, which is partly due to the lack of effective or targeted treatment...
